271 related articles for article (PubMed ID: 7532559)
1. Methylene blue administration in septic shock: a clinical trial.
Preiser JC; Lejeune P; Roman A; Carlier E; De Backer D; Leeman M; Kahn RJ; Vincent JL
Crit Care Med; 1995 Feb; 23(2):259-64. PubMed ID: 7532559
[TBL] [Abstract][Full Text] [Related]
2. Blockade of the action of nitric oxide in human septic shock increases systemic vascular resistance and has detrimental effects on pulmonary function after a short infusion of methylene blue.
Weingartner R; Oliveira E; Oliveira ES; Sant'Anna UL; Oliveira RP; Azambuja LA; Friedman G
Braz J Med Biol Res; 1999 Dec; 32(12):1505-13. PubMed ID: 10585632
[TBL] [Abstract][Full Text] [Related]
3. Does methylene blue administration to septic shock patients affect vascular permeability and blood volume?
Donati A; Conti G; Loggi S; Münch C; Coltrinari R; Pelaia P; Pietropaoli P; Preiser JC
Crit Care Med; 2002 Oct; 30(10):2271-7. PubMed ID: 12394955
[TBL] [Abstract][Full Text] [Related]
4. Methylene blue increases myocardial function in septic shock.
Daemen-Gubbels CR; Groeneveld PH; Groeneveld AB; van Kamp GJ; Bronsveld W; Thijs LG
Crit Care Med; 1995 Aug; 23(8):1363-70. PubMed ID: 7634806
[TBL] [Abstract][Full Text] [Related]
5. Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock.
Zhang H; Rogiers P; Preiser JC; Spapen H; Manikis P; Metz G; Vincent JL
Crit Care Med; 1995 Oct; 23(10):1711-21. PubMed ID: 7587237
[TBL] [Abstract][Full Text] [Related]
6. A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock.
Juffermans NP; Vervloet MG; Daemen-Gubbels CR; Binnekade JM; de Jong M; Groeneveld AB
Nitric Oxide; 2010 May; 22(4):275-80. PubMed ID: 20109575
[TBL] [Abstract][Full Text] [Related]
7. The effects of methylene blue on hemodynamic parameters and cytokine levels in refractory septic shock.
Park BK; Shim TS; Lim CM; Lee SD; Kim WS; Kim DS; Kim WD; Koh Y
Korean J Intern Med; 2005 Jun; 20(2):123-8. PubMed ID: 16134766
[TBL] [Abstract][Full Text] [Related]
8. Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock.
Gachot B; Bedos JP; Veber B; Wolff M; Regnier B
Intensive Care Med; 1995 Dec; 21(12):1027-31. PubMed ID: 8750129
[TBL] [Abstract][Full Text] [Related]
9. Methylene blue for the treatment of septic shock.
Paciullo CA; McMahon Horner D; Hatton KW; Flynn JD
Pharmacotherapy; 2010 Jul; 30(7):702-15. PubMed ID: 20575634
[TBL] [Abstract][Full Text] [Related]
10. Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study.
Avontuur JA; Tutein Nolthenius RP; van Bodegom JW; Bruining HA
Crit Care Med; 1998 Apr; 26(4):660-7. PubMed ID: 9559602
[TBL] [Abstract][Full Text] [Related]
11. Methylene blue improves the hepatopulmonary syndrome.
Schenk P; Madl C; Rezaie-Majd S; Lehr S; Müller C
Ann Intern Med; 2000 Nov; 133(9):701-6. PubMed ID: 11074903
[TBL] [Abstract][Full Text] [Related]
12. Use of methylene blue in patients with refractory septic shock: impact on hemodynamics and gas exchange.
Andresen M; Dougnac A; Díaz O; Hernández G; Castillo L; Bugedo G; Alvarez M; Dagnino J
J Crit Care; 1998 Dec; 13(4):164-8. PubMed ID: 9869542
[TBL] [Abstract][Full Text] [Related]
13. Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study.
Kirov MY; Evgenov OV; Evgenov NV; Egorina EM; Sovershaev MA; Sveinbjørnsson B; Nedashkovsky EV; Bjertnaes LJ
Crit Care Med; 2001 Oct; 29(10):1860-7. PubMed ID: 11588440
[TBL] [Abstract][Full Text] [Related]
14. Effects of nitric oxide donor SIN-1 on oxygen availability and regional blood flow during endotoxic shock.
Zhang H; Rogiers P; Friedman G; Preiser JC; Spapen H; Buurman WA; Vincent JL
Arch Surg; 1996 Jul; 131(7):767-74. PubMed ID: 8678780
[TBL] [Abstract][Full Text] [Related]
15. Effects of a nitric oxide synthase inhibitor in humans with septic shock.
Petros A; Lamb G; Leone A; Moncada S; Bennett D; Vallance P
Cardiovasc Res; 1994 Jan; 28(1):34-9. PubMed ID: 7509259
[TBL] [Abstract][Full Text] [Related]
16. Methylene blue reverses endotoxin-induced hypotension.
Keaney JF; Puyana JC; Francis S; Loscalzo JF; Stamler JS; Loscalzo J
Circ Res; 1994 Jun; 74(6):1121-5. PubMed ID: 8187278
[TBL] [Abstract][Full Text] [Related]
17. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock.
Robertson FM; Offner PJ; Ciceri DP; Becker WK; Pruitt BA
Arch Surg; 1994 Feb; 129(2):149-55; discussion 155-6. PubMed ID: 7508219
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
[TBL] [Abstract][Full Text] [Related]
19. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study.
Spies CD; Reinhart K; Witt I; Meier-Hellmann A; Hannemann L; Bredle DL; Schaffartzik W
Crit Care Med; 1994 Nov; 22(11):1738-46. PubMed ID: 7956276
[TBL] [Abstract][Full Text] [Related]
20. Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients.
Martin C; Viviand X; Arnaud S; Vialet R; Rougnon T
Crit Care Med; 1999 Sep; 27(9):1708-13. PubMed ID: 10507587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
